ScienceDex / Researcher record
Michael Voevodsky
- Mitochem Therapeutics Inc. (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2026
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2026): $320.8K in linked award amounts across 1 award record · Award-linked rank #41220.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2026 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 79678503Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2026 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award records by amount
NIH award records listing Michael Voevodsky as a PI. Multi-PI records show the full award amount for context.
- 1R43EY037591-01A1R43Contact PINovel gene mutation agnostic small molecule to treat retinitis pigmentosa$320.8Kaward amount
Award organization
Organizations that administered FY2026 awards listing Michael Voevodsky as a PI.
FY2026 award administered by Mitochem Therapeutics Inc. (SC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2026First NIH AwardMitochem Therapeutics Inc.
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Michael Voevodsky.